Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Editorial

Published on 04 Nov 2025

Editorial: Exploring microbial interactions in pancreatic ductal adenocarcinoma microenvironment

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Serena Veschi
Pierluigi Di Sebastiano
Gabriella Mincione

Frontiers in Oncology

doi 10.3389/fonc.2025.1725126

355 views

Original Research

Accepted on 03 Nov 2025

Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wencong Ma
mingtai hu
Zhihua Xie
Jianyang Ao
peining yan
Yao Huang
jinghan wang
xiaoqing jiang

Frontiers in Oncology

Original Research

Published on 03 Nov 2025

Global, regional, and national burden and trends of pancreatic cancer, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chunlong Liu
Pengpeng Liu
Xue Liu
Wang Niu
Panpan Wu
Jiangtao Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1671856

247 views

Original Research

Published on 03 Nov 2025

The prognostic value of the preoperative albumin-to-fibrinogen ratio in patients with intrahepatic cholangiocarcinoma: a multicenter retrospective propensity score matching analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yakai Yang
Junjie Kong
Tao Wang
Min Ji
Guangbing Li
Jun Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1633488

171 views

Case Report

Accepted on 31 Oct 2025

Mixed Adenoneuroendocrine Carcinoma of the Gallbladder: A Case Report and Review of the Literature

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yang Du
jiangnan Yang
Deyuan Fu

Frontiers in Oncology

Original Research

Accepted on 31 Oct 2025

Clinical Outcomes of Combination Therapy for Hepatocellular Carcinoma in a Predominantly Hispanic South Texas Population

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

John Hoverson
Jonathan Qi
Cameron Mehmken
Darian Chiu
Jack Lowry
Sukeshi Arora
Neil Newman

Frontiers in Oncology

Original Research

Published on 31 Oct 2025

Systemic immune-inflammation index: a key biomarker guiding personalized adjuvant chemotherapy in intrahepatic cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xin Yin
Yanjiang Yin
Wenzhuo Li
Jinliang Tong
Yi Liu
Jianping Chang
Jindong Ma
Yaoyu Xie
Xin Li
Hossein Mehrabanidil

Frontiers in Oncology

doi 10.3389/fonc.2025.1702336

365 views

Case Report

Published on 31 Oct 2025

Aggressive atypical cystic fibromatosis of the pancreas: a case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xianhong Yang
Zhenji Xu
Yangyingqiu Liu
Tao Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1596535

299 views

Review

Accepted on 30 Oct 2025

Extracellular derived-exosomal microRNAs in pancreatic cancer: Investigating their diagnostic importance and potential targets for the prevention and treatment in pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Rashid Mir
ulfat Jan
Jameel Barnawi
Naseh A Algehainy
Mohammed M Jalal
Malik A. Altayar
Reem almotairi
Tarig Ms Alnour
SYED Khalid Mustafa
Abdulaziz S Al-Otaibi

Frontiers in Oncology

Correction

Accepted on 30 Oct 2025

Correction: Real-World Challenges in Hepatocellular Carcinoma in Central America and the Caribbean: Insights from a multinational expert survey

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Christie Perelló
Hugo Disla
Pablo Coste
Marisabell Valdez
Dayron Páez
Carlos Rivera
Yong Loo
Tania Mayorga
Kenia Torres
Edwyn Pol

Frontiers in Oncology

Case Report

Accepted on 29 Oct 2025

Spontaneous Tumor Lysis Syndrome Following Liver Biopsy: A Case Report and Literature Review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wenchao Mao
Xiangyang Jiang
Minjia Wang
Kailun Cai
Weihang Hu
Shijin Gong
Yuexi Zhao

Frontiers in Oncology

Systematic Review

Accepted on 29 Oct 2025

Efficacy and safety of TACE/HAIC combined with targeted immunotherapy versus targeted immunotherapy for advanced hepatocellular carcinoma: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuting Liao
Wenliang Zhu
Jianquan Zhang

Frontiers in Oncology

Original Research

Accepted on 29 Oct 2025

Clinical Management and Prognostic Determinants of Gallbladder Neuroendocrine Carcinoma: A Single-Institutional Analysis of 31 Cases

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuting Luo
Yu Zhou
Gang Wang
Saud Ahmad Saad
Zhen You
Dan Jiang

Frontiers in Oncology

Original Research

Accepted on 28 Oct 2025

Efficacy and Survival Prognosis Analysis of Surgical Resection Combined with Targeted Therapy in Patients with Colorectal Cancer Liver Metastasis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yan Feihu
Shi Yun Jie
Zheng Chun Kang
Hantao Wang
Xu Li

Frontiers in Oncology

103 views

Case Report

Published on 28 Oct 2025

Case Report: Metachronous pancreatic adenocarcinoma following HER2-positive breast cancer and the implications of non-BRCA germline variants with TP53-mutant disease

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jing Chen
Hui Chun Zhou
Min Hui Fan
Mei-yao Qin

Frontiers in Oncology

doi 10.3389/fonc.2025.1705199

322 views

Systematic Review

Accepted on 27 Oct 2025

Efficacy and Safety of Sorafenib Combined with Transarterial Chemoembolization (TACE) in the Treatment of Hepatocellular Carcinoma:A Meta-Analysis of Randomized Controlled Trials

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lixiu Yu
Yi Xiong
Jing Liao
Yahui Deng
Xuejia Zhai

Frontiers in Oncology

127 views